The draft update of Annex 1 has introduced the requirement for pharmaceutical manufacturers to have in place a Contamination Control Strategy (CCS).
Whether you’re in the process of defining, developing or maintaining your CCS, we can work with you to help build a compliant strategy for cleaning, disinfection and decontamination.
Our complimentary series of GTC webinars covers all aspects of developing, building and maintaining your Contamination Control Strategy as well as how Ecolab’s exclusive program can help you easily refine your CCS for cleaning, disinfection and decontamination.
The GTC team proactively monitor regulatory changes in industry through engagement with regulatory bodies such as EU GMP, USP, PDA, CEN and EPA.
Our GTC will conduct an in-depth review to help identify and document the risks to your cleanroom and work to close any gaps in your strategy.
Ecolab offers comprehensive documentation packages to rationalise acceptance of risks or document the contamination control solution that has been implemented to mitigate risks.
Our GTC team are experts in the validation processes and can support you through the activities needed to perform compliant and successful validations as part of your Contamination Control Strategy